openPR Logo
Press release

Traumatic Brain Injury Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals | Neuren Pharmaceuticals Ltd., NeuroVive Pharmaceutical AB, Stemedica Cell Technologies Inc., Grace Laboratories LLC., Integra LifeSciences Corporation, Medtronic

12-07-2023 06:29 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Traumatic Brain Injury Pipeline Analysis, 2023 Updates | Latest

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Traumatic Brain Injury pipeline constitutes key companies continuously working towards developing Traumatic Brain Injury treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Traumatic Brain Injury Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Traumatic Brain Injury Market.

The Traumatic Brain Injury Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Traumatic Brain Injury Pipeline Report: https://www.delveinsight.com/sample-request/traumatic-brain-injury-tbi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Traumatic Brain Injury treatment therapies with a considerable amount of success over the years.
• Traumatic Brain Injury companies working in the treatment market are Odyssey Group, Pinteon Therapeutics, Vasopharm, SanBio, NeuroTrauma Sciences, ALSP Inc., AlzeCure, and others, are developing therapies for the Traumatic Brain Injury treatment
• Emerging Traumatic Brain Injury therapies in the different phases of clinical trials are- PRV 002, PNT001, VAS203, Vandefitemcel, NTS-105, Research Program, ACD856, and others are expected to have a significant impact on the Traumatic Brain Injury market in the coming years.
• In July 2022, Japan's Ministry of Health, Labour, and Welfare (MHLW) declared the convening of the Regenerative Medicine Subcommittee meeting on August 3. Notably, the discussions will not cover SanBio's SB623, presently under evaluation in the Sakigake Designation System for treating traumatic brain injury.

Traumatic Brain Injury Overview
Traumatic Brain Injury (TBI) is defined by the American Association of Neurological Surgeons (2022) as a disruption in the normal function of the brain that can be brought on by a blow, bump, or jolt to the head, by the head striking an object suddenly and violently, or when an object pierces the skull and enters the brain.

Get a Free Sample PDF Report to know more about Traumatic Brain Injury Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/traumatic-brain-injury-tbi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Traumatic Brain Injury Drugs Under Different Phases of Clinical Development Include:
• NTS-105: NeuroTrauma Sciences
• Research Program: ALSP Inc.
• ACD856: AlzeCure
• PRV 002: Odyssey Group
• PNT001: Pinteon Therapeutics
• VAS203: Vasopharm
• Vandefitemcel: SanBio

Traumatic Brain Injury Route of Administration
Traumatic Brain Injury pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Traumatic Brain Injury Molecule Type
Traumatic Brain Injury Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Traumatic Brain Injury Pipeline Therapeutics Assessment
• Traumatic Brain Injury Assessment by Product Type
• Traumatic Brain Injury By Stage and Product Type
• Traumatic Brain Injury Assessment by Route of Administration
• Traumatic Brain Injury By Stage and Route of Administration
• Traumatic Brain Injury Assessment by Molecule Type
• Traumatic Brain Injury by Stage and Molecule Type
DelveInsight's Traumatic Brain Injury Report covers around products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Traumatic Brain Injury product details are provided in the report. Download the Traumatic Brain Injury pipeline report to learn more about the emerging Traumatic Brain Injury therapies at:
https://www.delveinsight.com/sample-request/traumatic-brain-injury-tbi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Traumatic Brain Injury Therapeutics Market include:
Key companies developing therapies for Traumatic Brain Injury are - Neuren Pharmaceuticals Ltd., NeuroVive Pharmaceutical AB, Stemedica Cell Technologies Inc., Grace Laboratories LLC., Integra LifeSciences Corporation, Medtronic PLC, TEVA Pharmaceutical Industries Ltd., Vasopharm GmbH, among others.

Traumatic Brain Injury Pipeline Analysis:
The Traumatic Brain Injury pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Traumatic Brain Injury with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Traumatic Brain Injury Treatment.
• Traumatic Brain Injury key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Traumatic Brain Injury Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Traumatic Brain Injury market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Traumatic Brain Injury drugs and therapies-
https://www.delveinsight.com/sample-request/traumatic-brain-injury-tbi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Traumatic Brain Injury Pipeline Market Drivers
• Increase in the prevalence of Brain Injuries are some of the important factors that are fueling the Traumatic Brain Injury Market.

Traumatic Brain Injury Pipeline Market Barriers
• However, less Robust pipeline, side-effects associated and other factors are creating obstacles in the Traumatic Brain Injury Market growth.

Scope of Traumatic Brain Injury Pipeline Drug Insight
• Coverage: Global
• Key Traumatic Brain Injury Companies: Odyssey Group, Pinteon Therapeutics, Vasopharm, SanBio, NeuroTrauma Sciences, ALSP Inc., AlzeCure, and others
• Key Traumatic Brain Injury Therapies: PRV 002, PNT001, VAS203, Vandefitemcel, NTS-105, Research Program, ACD856, and others
• Traumatic Brain Injury Therapeutic Assessment: Traumatic Brain Injury current marketed and Traumatic Brain Injury emerging therapies
• Traumatic Brain Injury Market Dynamics: Traumatic Brain Injury market drivers and Traumatic Brain Injury market barriers

Request for Sample PDF Report for Traumatic Brain Injury Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/traumatic-brain-injury-tbi-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Traumatic Brain Injury Report Introduction
2. Traumatic Brain Injury Executive Summary
3. Traumatic Brain Injury Overview
4. Traumatic Brain Injury- Analytical Perspective In-depth Commercial Assessment
5. Traumatic Brain Injury Pipeline Therapeutics
6. Traumatic Brain Injury Late Stage Products (Phase II/III)
7. Traumatic Brain Injury Mid Stage Products (Phase II)
8. Traumatic Brain Injury Early Stage Products (Phase I)
9. Traumatic Brain Injury Preclinical Stage Products
10. Traumatic Brain Injury Therapeutics Assessment
11. Traumatic Brain Injury Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Traumatic Brain Injury Key Companies
14. Traumatic Brain Injury Key Products
15. Traumatic Brain Injury Unmet Needs
16 . Traumatic Brain Injury Market Drivers and Barriers
17. Traumatic Brain Injury Future Perspectives and Conclusion
18. Traumatic Brain Injury Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Traumatic Brain Injury Market https://www.delveinsight.com/report-store/traumatic-brain-injury-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Traumatic Brain Injury Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Traumatic Brain Injury Epidemiology https://www.delveinsight.com/report-store/traumatic-brain-injury-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Traumatic Brain Injury Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
https://www.delveinsight.com/report-store/gynecological-devices-market
Gynecological Devices Market By Product (Gynecological Endoscopy Devices [Hysteroscope, Resectoscope, And Others), Endometrial Ablation Devices [Balloon Ablation Devices, Radiofrequency Ablation Devices, And Others], Contraceptive Devices [Temporary Birth Control And Permanent Birth Control], Diagnostic Imaging Systems, Fluid Management Systems, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of various gynecological ailments and increasing figure of surgical procedures across the globe.

Baby Wipes Market
https://www.delveinsight.com/report-store/baby-wipes-market
Baby Wipes Market By (Wet Wipes And Dry Wipes), By Distribution Channels (Supermarkets And Hypermarkets, E-Commerce, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to increased adoption of baby wipes for maintaining infant sanitation and increasing product development activities.

Probiotics Market
https://www.delveinsight.com/report-store/probiotics-market
Probiotics Market By Ingredient Type (Bacteria And Yeast), By Product Type (Functional Food And Beverages, Dietary Supplements, And Animal Feed), By Application (Human Nutrition And Animal Nutrition), By Distribution Channels (Supermarkets And Hypermarkets, Convenience Stores, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to rising demand for probiotics as a preventive healthcare and increasing product development activities.

Artificial Tears Market
https://www.delveinsight.com/report-store/artificial-tears-market
Artificial Tears Market By Product (Cellulose-Derived Tears, Glycerin-Derived Tears, Polyethylene Glycol And Propylene Glycol-Based Tears, And Others), By Delivery Method (Eye Drops And Eye Ointments), By Application (Dry Eye Disease, Allergies And Infections, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence dry eyes syndrome and increasing availability of over the counter (otc) artificial tears.

Non-invasive Prenatal Testing Market https://www.delveinsight.com/report-store/non-invasive-prenatal-testing-market
Non-Invasive Prenatal Testing Market By Product Type (Instruments And Kits And Reagents), By Indication (Down Syndrome, Edwards Syndrome, Patau Syndrome, Turner Syndrome, And Others), By End-User (Hospitals, Diagnostic Labs, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of chromosomal disorders and the increasing demand for early and non-invasive fetal diagnosis across the globe.

Orthopedic Implants Market https://www.delveinsight.com/report-store/orthopedic-implants-market
Orthopedic Implants Market By Product Type (Hip Implants, Knee Implants, Spinal Implants, Foot And Ankle Implants, And Others), By End-User (Hospitals, Orthopedic Clinics, And Others ), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to increasing prevalence of orthopedic diseases and rising demand for personalized orthopedic implants.

Analgesics Market
https://www.delveinsight.com/report-store/analgesics-market
Analgesics Market By Product Type (Opioid And Non-Opioid), By Application (Musculoskeletal, Surgical And Trauma, Cancer, And Others), By Drug Type (Prescription And Over-The-Counter (Otc)) By Distribution Channels (Hospital Pharmacy & Retail Pharmacy, And E-Commerce) by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to the increasing prevalence of orthopedic, cancer, and other chronic diseases and rising demand of analgesics for the treatment of mild to moderate pain.

Animal Nutrition Market
https://www.delveinsight.com/report-store/animal-nutrition-market
Animal Nutrition Market By Product Type (Amino Acids, Enzymes, Vitamins And Minerals, Medicated Feed Additives, Antioxidants, And Others), By Animal Type (Poultry, Ruminant, Pet Food, And Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to rising awareness on animal health and nutrition and increasing industrialisation of livestock production.

Point of Care Diagnostics Market
https://www.delveinsight.com/report-store/point-of-care-diagnostics-market
Point of Care Diagnostics Market By Product Type (Instruments, Kits And Reagents), By Application (Blood Glucose Monitoring, Infectious Diseases, Cardio-Metabolic Diseases, Pregnancy & Fertility Testing, And Others), By End-User (Hospitals, Diagnostic Centers, Home Care Settings, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of infectious and other lifestyle based disorders such as diabetes and cardiovascular diseases and growing awareness on health.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Traumatic Brain Injury Pipeline Analysis, 2023 Updates | Latest FDA, EMA, and PMDA Approvals | Neuren Pharmaceuticals Ltd., NeuroVive Pharmaceutical AB, Stemedica Cell Technologies Inc., Grace Laboratories LLC., Integra LifeSciences Corporation, Medtronic here

News-ID: 3319850 • Views:

More Releases from DelveInsight Business Research

Lumateperone (Caplyta) by Intra-Cellular Therapies Inc. expected to drive market size of Major Depressive Disorder
Lumateperone (Caplyta) by Intra-Cellular Therapies Inc. expected to drive market …
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on Lumateperone (Intra-Cellular Therapies Inc.) providing insights into the drug market landscape and market forecast of Lumateperone (Caplyta) upto 2032. The report, titled "XXXXX" is now available for review and analysis. Are you interested in finding out the projected market size of Lumateperone in 2032? Lumateperone Market Forecast https://www.delveinsight.com/report-store/lumateperone-emerging-drug-insight-and-market-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr The Lumateperone Market Report
ABVC BioPharma's
ABVC BioPharma's "ABV-1504" market size expected to increase many folds by 2032, …
[Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth report on ABV-1504 (ABVC BioPharma) providing insights into the drug market landscape and market forecast of ABV-1504 upto 2032. The report, titled "ABV-1504 Market Size, Forecast, and Emerging Insight - 2032" is now available for review and analysis. Are you interested in finding out the projected market size of ABV-1504 in 2032? ABV-1504 Market
Acute Pain Market is expected to grow at a CAGR of 8.3% during the Study Period (2019-2032), Assesses DelveInsight
Acute Pain Market is expected to grow at a CAGR of 8.3% during the Study Period …
DelveInsight's Acute Pain Market Insights report includes a comprehensive understanding of current treatment practices, acute pain emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan]. Request for Sample Report @ https://www.delveinsight.com/report-store/acute-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr Key Takeaways from the Acute Pain Market Report • As per DelveInsight analysis, the acute pain market
Projections Show Moderate Growth for the Adenoid Cystic Carcinoma Market by 2032 - DelveInsight Analysis Highlights Key Players Including Merck, Bayer, Novartis Pharmaceuticals, Pfizer, Elevar Therapeutics, and Ayala Pharmaceuticals
Projections Show Moderate Growth for the Adenoid Cystic Carcinoma Market by 2032 …
The Adenoid Cystic Carcinoma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage pipeline products will significantly revolutionize the Adenoid Cystic Carcinoma market dynamics. DelveInsight's "Adenoid Cystic Carcinoma - Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Adenoid Cystic Carcinoma, historical and forecasted epidemiology as well as the Adenoid Cystic Carcinoma market trends in

All 5 Releases


More Releases for Trauma

Global Trauma Straight Plate System Market Report 2019 Companies included Synthe …
#7th Edition Trauma Straight Plate System market report recently has been published by market reports company. It features comprehensive market outlook based on historic data from 2013 to 2018 and estimated market trends during the forecast period from 2018 to 2026. To access complete insights of global Trauma Straight Plate System market report: sales@marketreportscompany.com The Trauma Straight Plate System market delivers a wide array of primary and secondary data with respect
Spinal Cord Trauma Treatment Market : Partial spinal cord trauma Worth US$ 1,870 …
This market is segmented into five regions such as North America, Latin America, Europe, APAC and MEA. Asia-Pacific account for the largest market share in the global spinal cord trauma treatment market. Large patient population due to the high rate of road accidents and crime is making the Asia Pacific region most attractive market for spinal cord trauma treatment. On the other hand, MEA and Latin America is expected to
Global Trauma Product Industry
Global Trauma Product Industry Market Insights:  The Global Trauma Products market is expected to grow at a CAGR of 7.2% during 2017-2022. The products that are used for the physical injuries and wounds caused by the external sources are known as trauma products. Traumatic injuries sometimes lead to long term complications such as long-term disability, chronic pain and infections and so on. It includes the injuries causing severe damage to the body
Spinal Trauma Devices Market: Spinal Trauma Devices Sales to Surge Rapidly in Re …
The global spinal trauma devices market is dynamic and highly competitive. Only a couple of companies account for a substantial share in the market, thus lending it an oligopolistic vendor landscape. The market is largely dominated by DePuy Synthes, Medtronic, NuVasive, Inc., Stryker Corporation, and Globus Medical, Inc. The cumulative share of these companies added up to 79.1% in 2014, says Transparency Market Research (TMR) in a new report. As
Spinal Trauma Devices Market 10.56% CAGR to 2021 Driven by Increasing Incidence …
The report covers the present scenario and the growth prospects of the global spinal trauma devices market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. Spinal trauma refers to a severe injury to the spinal cord. It can occur due to accidents, falls, violence like a gunshot, or infections and requires
Orthopedic Trauma Devices Market to Grow Globally
Orthopedic Trauma Devices Market Overview Orthopedic trauma is a condition that includes injuries mainly affecting the human skeleton and deteriorating the condition of the subject. It includes the conditions ranging from simple fracture to severe life threatening injuries that are caused due to accidents. Orthopedic trauma includes multiple broken bones across different parts of the body that involve extensive reconstructive surgery. Severe orthopedic traumas can only be treated by fracture specialists